Anti IL-18 (GSK1070806) in Behcet's Disease

NCT03522662 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Behcet's Disease

Interventions

DRUG: GSK1070806

Sponsor

Cambridge University Hospitals NHS Foundation Trust